[a-Cyclodextrin](1).[Ebselen] |
1.00 |
|
7.0 |
25.0 |
phase solubility |
Kaneto Uekama 2002 |
[a-Cyclodextrin](2).[Ebselen] |
1.70 |
|
7.0 |
25.0 |
phase solubility |
Kaneto Uekama 2002 |
[sulfobutylether-b-cyclodextrin](1).[Ebselen] |
3.43 |
|
7.0 |
25.0 |
phase solubility |
Kaneto Uekama 2002 |
[sulfobutylether-b-cyclodextrin](1).[Ebselen] |
3.56 |
|
7.0 |
25.0 |
1H-NMR |
Kaneto Uekama 2002 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[Ebselen] |
3.00 |
|
7.0 |
25.0 |
phase solubility |
Kaneto Uekama 2002 |
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Ebselen] |
2.90 |
|
7.0 |
25.0 |
phase solubility |
Kaneto Uekama 2002 |
[b-Cyclodextrin](1).[Ebselen] |
2.68 |
|
7.0 |
25.0 |
phase solubility |
Kaneto Uekama 2002 |
[G2-b-CD](1).[Ebselen] |
2.63 |
|
7.0 |
25.0 |
phase solubility |
Kaneto Uekama 2002 |
[g-Cyclodextrin](1).[Ebselen] |
2.00 |
|
7.0 |
25.0 |
phase solubility |
Kaneto Uekama 2002 |
[2-O-(2-Hydroxy)butyl-b-Cyclodextrin](1).[Ebselen] |
3.20 |
|
7.0 |
25.0 |
phase solubility |
Kaneto Uekama 2002 |